Daniel Friedman

Principal at BroadOak Capital

Speaker

Daniel is a Principal on BroadOak’s investing team, covering the firm's life science tools portfolio, with a focus on products with cell and gene therapy applications. Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for clinical-stage biotechnology companies. Daniel currently serves as a Board Director at PBS Biotech and as Secretary of the Board at Biolog.